Abstract
Background Lung transplantation is the final option for end-stage respiratory diseases. Postoperative monitoring of patients’ physical condition and performance of appropriate interventions for any abnormalities are important to improve the long-term success of lung transplantation. In Japan, patients’ handwritten self-management charts are widely used to record data for home spirometry, vital signs, and medication dosages. However, handwritten data are not suitable for assessment. We developed an internet-based real-time monitoring system (LT-FollowUp) that can easily assess patient data and detect any abnormalities that arise without delay. The aim of this pilot study was to examine the acceptability of LT-FollowUp to patients.
Methods This was a prospective single-arm pilot cohort study. Lung transplant patients were recruited consecutively at regular outpatient visits from October 2020. Patients were instructed to enter their self-measurements (pulmonary functions and vital signs) and immunosuppressant dosages twice a day.
Acceptability was assessed by the data filling rate. The changes in filling rate over time were evaluated using a linear mixed-effects model for repeated measurements.
Results A total of 19 patients were included in the study. There were no significant differences in the filling rates between the handwritten charts and LT-FollowUp.
Conclusion LT-FollowUp is an acceptable system for patients. Further development of the LT-FollowUp system may lead to better long-term clinical outcomes of lung transplantation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by grants-in-aid for scientific research from KAKENHI (21K16508)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of The University of Tokyo (2020156NI).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Grant information: grants-in-aid for scientific research from KAKENHI (21K16508)
Abbreviations: N/A
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
